Full Application for DoD Breakthrough Award Level 2: Targeting PTPN2 to promote anti-tumor immunity in triple negative breast cancer

  • Tiganis, Tony (Primary Chief Investigator (PCI))
  • McLean, Catriona (Chief Investigator (CI))
  • Loi, Sherene (Chief Investigator (CI))
  • Wiede, Florian (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date1/03/21 → 29/02/24

Funding

  • US Army Medical Research Acquisition Activity

Keywords

  • Phosphatases, triple negative breast cancer, immune checkpoints, tumor infiltrating lymphocytes, T cells, anti-tumor immunity, signal transducer and activators of transcription, tumor immunology